{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T15:30:56Z","timestamp":1795102256990,"version":"4.10.3"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019897","name":"GenScript Biotech Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.vaccine.2025.128055","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T07:55:56Z","timestamp":1764834956000},"page":"128055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A novel alphavirus-based saRNA platform for enhanced vaccination efficacy and organ-specific targeting"],"prefix":"10.1016","volume":"72","author":[{"given":"Zhen","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.128055_bb0005","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines \u2014 a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.vaccine.2025.128055_bb0010","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.3390\/ijms24032700","article-title":"A comprehensive review of mRNA vaccines","volume":"24","author":"Gote","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2025.128055_bb0015","series-title":"Manufacturing strategy for the production of 200 million sterile doses of an mRNA vaccine for COVID-19","author":"Labarta","year":"2021"},{"key":"10.1016\/j.vaccine.2025.128055_bb0020","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.vaccine.2021.03.038","article-title":"mRNA vaccines manufacturing: challenges and bottlenecks","volume":"39","author":"Rosa","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128055_bb0025","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1021\/acs.nanolett.9b04246","article-title":"Ionizable lipid nanoparticle-mediated mRNA delivery for human CAR T cell engineering","volume":"20","author":"Billingsley","year":"2020","journal-title":"Nano Lett"},{"key":"10.1016\/j.vaccine.2025.128055_bb0030","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1021\/acs.nanolett.3c03509","article-title":"Predictive High-Throughput Platform for Dual Screening of mRNA Lipid Nanoparticle Blood\u2013Brain Barrier Transfection and Crossing","volume":"24","author":"Han","year":"2024","journal-title":"Nano Lett"},{"key":"10.1016\/j.vaccine.2025.128055_bb0035","article-title":"Lipid-polymer hybrid \u201cparticle-in-particle\u201d nanostructure gene delivery platform explored for Lyophilizable DNA and mRNA COVID-19 vaccines","volume":"32","author":"Li","year":"2022","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.vaccine.2025.128055_bb0040","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41417-022-00435-8","article-title":"Next generation self-replicating RNA vectors for vaccines and immunotherapies","volume":"30","author":"Aliahmad","year":"2023","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.vaccine.2025.128055_bb0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41434-020-00204-y","article-title":"Self-amplifying RNA vaccines for infectious diseases","volume":"28","author":"Bloom","year":"2021","journal-title":"Gene Ther"},{"key":"10.1016\/j.vaccine.2025.128055_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112884","article-title":"Self-amplifying RNA approach for protein replacement therapy","volume":"23","author":"Papukashvili","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2025.128055_bb0055","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.ymthe.2021.04.001","article-title":"A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice","volume":"29","author":"De Alwis","year":"2021","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2025.128055_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114204","article-title":"Less is more: self-amplifying mRNA becomes self-killing upon dose escalation in immune-competent retinal cells","volume":"196","author":"Vanluchene","year":"2024","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.vaccine.2025.128055_bb0065","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1473-3099(24)00060-4","article-title":"Persistence of immune responses of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2","volume":"24","author":"Oda","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128055_bb0070","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1038\/s41467-024-47905-1","article-title":"Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials","volume":"15","author":"H\u1ed3","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2025.128055_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113900","article-title":"Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: getting the message across","volume":"176","author":"Minnaert","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2025.128055_bb0080","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1021\/acsnano.0c00326","article-title":"Big is beautiful: enhanced saRNA delivery and immunogenicity by a higher molecular weight, bioreducible, Cationic Polymer","volume":"14","author":"Blakney","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.vaccine.2025.128055_bb0085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.omtn.2022.11.024","article-title":"Formulation, inflammation, and RNA sensing impact the immunogenicity of self-amplifying RNA vaccines","volume":"31","author":"Tregoning","year":"2023","journal-title":"Mol Ther - Nucleic Acids"},{"key":"10.1016\/j.vaccine.2025.128055_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103341","article-title":"Self-amplifying mRNA vaccines: mode of action, design, development and optimization","volume":"27","author":"Pourseif","year":"2022","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.vaccine.2025.128055_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202402936","article-title":"A novel self-amplifying mRNA with decreased cytotoxicity and enhanced protein expression by macrodomain mutations","volume":"11","author":"Gong","year":"2024","journal-title":"Adv Sci"},{"key":"10.1016\/j.vaccine.2025.128055_bb0100","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3390\/v16040503","article-title":"Trans-amplifying RNA: a journey from alphavirus research to future vaccines","volume":"16","author":"Y\u0131ld\u0131z","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2025.128055_bb0105","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ymthe.2024.12.055","article-title":"Alphaviral backbone of self-amplifying RNA enhances protein expression and immunogenicity against SARS-CoV-2 antigen","volume":"33","author":"Casmil","year":"2025","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2025.128055_bb0110","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1089\/hum.2017.121","article-title":"Improvement of in vivo expression of genes delivered by self-amplifying RNA using vaccinia virus immune evasion proteins","volume":"28","author":"Beissert","year":"2017","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2025.128055_bb0115","doi-asserted-by":"crossref","first-page":"6932","DOI":"10.1038\/s41598-019-43422-0","article-title":"In vitro evolution of enhanced RNA replicons for immunotherapy","volume":"9","author":"Li","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2025.128055_bb0120","unstructured":"Strauss, J. H. & Strauss, E. G. The alphaviruses: gene expression, replication, and evolution. Microbiol Rev."},{"key":"10.1016\/j.vaccine.2025.128055_bb0125","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001644","article-title":"Alphaviruses: host pathogenesis, immune response, and vaccine & treatment updates","volume":"102","author":"Guerrero-Arguero","year":"2021","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2025.128055_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/249640","article-title":"Replication of alphaviruses: a review on the entry process of alphaviruses into cells","volume":"2011","author":"Leung","year":"2011","journal-title":"Adv Virol"},{"key":"10.1016\/j.vaccine.2025.128055_bb0135","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev-immunol-101220-014952","article-title":"Distinct cellular tropism and immune responses to alphavirus infection","volume":"40","author":"Kafai","year":"2022","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2025.128055_bb0140","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41551-023-01142-x","article-title":"Genetically encoding multiple functionalities into extracellular vesicles for the targeted delivery of biologics to T cells","volume":"8","author":"Stranford","year":"2023","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.vaccine.2025.128055_bb0145","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1038\/s41467-024-50093-7","article-title":"Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation","volume":"15","author":"Su","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2025.128055_bb0150","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jconrel.2024.08.030","article-title":"Enhancing RNA-lipid nanoparticle delivery: organ- and cell-specificity and barcoding strategies","volume":"375","author":"Wei","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2025.128055_bb0155","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/nrm.2017.103","article-title":"Functional 5\u2032 UTR mRNA structures in eukaryotic translation regulation and how to find them","volume":"19","author":"Leppek","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.vaccine.2025.128055_bb0160","series-title":"Compositions and methods for preparing capped mrna","author":"Cheng-Hsien","year":"2025"},{"key":"10.1016\/j.vaccine.2025.128055_bb0165","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.ymthe.2020.11.011","article-title":"Innate inhibiting proteins enhance expression and immunogenicity of self-amplifying RNA","volume":"29","author":"Blakney","year":"2021","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2025.128055_bb0170","doi-asserted-by":"crossref","first-page":"10118","DOI":"10.1128\/JVI.75.21.10118-10131.2001","article-title":"Evolutionary relationships and systematics of the alphaviruses","volume":"75","author":"Powers","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.128055_bb0175","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jconrel.2024.07.078","article-title":"Delivery vehicle and route of administration influences self-amplifying RNA biodistribution, expression kinetics, and reactogenicity","volume":"374","author":"Bathula","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2025.128055_bb0180","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1038\/s41467-018-06002-w","article-title":"Development of an antibody fragment that stabilizes GPCR\/G-protein complexes","volume":"9","author":"Maeda","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2025.128055_bb0185","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/s41385-022-00540-9","article-title":"Chemokine receptor CCR9 suppresses the differentiation of CD4+CD8\u03b1\u03b1+ intraepithelial T cells in the gut","volume":"15","author":"Li","year":"2022","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2025.128055_bb0190","doi-asserted-by":"crossref","first-page":"548","DOI":"10.14348\/molcells.2015.0044","article-title":"Expression analyses revealed Thymic stromal co-transporter\/Slc46A2 is in stem cell populations and is a putative tumor suppressor","volume":"38","author":"Kim","year":"2015","journal-title":"Mol Cell"},{"key":"10.1016\/j.vaccine.2025.128055_bb0195","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/vaccines9020097","article-title":"An update on self-amplifying mRNA vaccine development","volume":"9","author":"Blakney","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2025.128055_bb0200","series-title":"Complete substitution with modified nucleotides suppresses the early interferon response and increases the potency of self-amplifying RNA. Preprint at","author":"McGee","year":"2023"},{"key":"10.1016\/j.vaccine.2025.128055_bb0205","doi-asserted-by":"crossref","first-page":"10708","DOI":"10.1073\/pnas.1408677111","article-title":"Enhancement of protein expression by alphavirus replicons by designing self-replicating subgenomic RNAs","volume":"111","author":"Kim","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2025.128055_bb0210","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1261\/rna.077099.120","article-title":"Phosphodiester modifications in mRNA poly(a) tail prevent deadenylation without compromising protein expression","volume":"26","author":"Strzelecka","year":"2020","journal-title":"RNA"},{"key":"10.1016\/j.vaccine.2025.128055_bb0215","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41580-021-00417-y","article-title":"Roles of mRNA poly(a) tails in regulation of eukaryotic gene expression","volume":"23","author":"Passmore","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.vaccine.2025.128055_bb0220","series-title":"Incorporation of 5 methylcytidine alleviates innate immune response to self-amplifying RNA vaccine. Preprint at","author":"Komori","year":"2023"},{"key":"10.1016\/j.vaccine.2025.128055_bb0225","doi-asserted-by":"crossref","first-page":"17634","DOI":"10.1038\/s41598-024-68617-y","article-title":"1m\u03a8 influences the performance of various positive-stranded RNA virus-based replicons","volume":"14","author":"Miyazato","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2025.128055_bb0230","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ymthe.2024.12.055","article-title":"Alphaviral backbone of self-amplifying RNA enhances protein expression and immunogenicity against SARS-CoV-2 antigen","volume":"33","author":"Casmil","year":"2025","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2025.128055_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121339","article-title":"In situ T-cell transfection by anti-CD3-conjugated lipid nanoparticles leads to T-cell activation, migration, and phenotypic shift","volume":"281","author":"Kheirolomoom","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2025.128055_bb0240","article-title":"Targeting strategies for mRNA delivery","volume":"14","author":"Meyer","year":"2022","journal-title":"Mater Today Adv"},{"key":"10.1016\/j.vaccine.2025.128055_bb0245","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.vaccine.2025.128055_bb0250","doi-asserted-by":"crossref","unstructured":"Silva, L. A. & Dermody, T. S. Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies. J Clin Invest 127, 737\u2013749.","DOI":"10.1172\/JCI84417"},{"key":"10.1016\/j.vaccine.2025.128055_bb0255","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3390\/pathogens10030357","article-title":"Ross River virus infection: a cross-disciplinary review with a veterinary perspective","volume":"10","author":"Yuen","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.vaccine.2025.128055_bb0260","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2217\/fvl.11.50","article-title":"Endemic Venezuelan equine encephalitis in the Americas: hidden under the dengue umbrella","volume":"6","author":"Aguilar","year":"2011","journal-title":"Future Virol"},{"key":"10.1016\/j.vaccine.2025.128055_bb0265","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.4269\/ajtmh.17-0927","article-title":"Eastern equine encephalitis virus in the United States, 2003\u20132016","volume":"98","author":"Lindsey","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2025.128055_bb0270","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12941-020-00360-4","article-title":"Venezuelan equine encephalitis virus: the problem is not over for tropical America","volume":"19","author":"Guzm\u00e1n-Ter\u00e1n","year":"2020","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.vaccine.2025.128055_bb0275","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1128\/jvi.67.3.1269-1277.1993","article-title":"Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5\u2032-noncoding region and the E2 envelope glycoprotein","volume":"67","author":"Kinney","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.128055_bb0280","doi-asserted-by":"crossref","first-page":"eaau6085","DOI":"10.1126\/sciimmunol.aau6085","article-title":"Structure-function of the immune system in the spleen","volume":"4","author":"Lewis","year":"2019","journal-title":"Sci Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25013532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25013532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T04:59:21Z","timestamp":1768453161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25013532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":56,"alternative-id":["S0264410X25013532"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128055","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel alphavirus-based saRNA platform for enhanced vaccination efficacy and organ-specific targeting","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128055"}}